Learning, Inspiring, Sharing
Personalized Screening for Breast Cancer
Includes a Live Web Event on 11/12/2025 at 7:00 PM (EST)
Learning Objective(s)
After watching this collaborative activity with GE HealthCare, you should be able to:
- Implement evidence-based personalized screening recommendations to all patients presenting for breast cancer screening;
- Utilize risk assessment models to uncover high-risk patients requiring genetic testing and supplemental screening with US and MRI; and
- Monitor outcomes of the personalized screening program utilizing a dedicated supplemental audit.
Faculty: Lisa R. Stempel, MD
Target Audience: This webinar is designed to meet the needs of medical professionals who practice breast imaging, genetic counseling, and high-risk practitioners.
AIUM Member: $0
Nonmember: $0
Your fee includes access to the content.
This webinar is a non-CME educational activity.
Not applicable
Lisa R. Stempel, MD
Chief, Division of Breast Imaging Director High-Risk Cancer Screening Program Associate Professor, Diagnostic Radiology & Nuclear Medicine RUSH | Cancer Center Rush University Medical Center
Dr. Lisa Stempel is a board-certified diagnostic radiologist specializing in breast imaging. As Chief of the Division of Breast Imaging at Rush, she leads efforts in early cancer detection using advanced technologies such as mammography, ultrasound, ABUS, Contrast Enhanced Mammography (CEM) and MRI. Her work focuses on utilizing personalized screening recommendations to identify small, treatable cancers, particularly in women with dense breast tissue or elevated risk, offering patients both clinical precision and compassionate care.
